in	O
1966	O
he	O
was	O
allowed	O
to	O
work	O
for	O
the	O
national	building-theater
theatre	building-theater
again	O
.	O

it	O
was	O
originally	O
designed	O
to	O
equip	O
the	O
su-100	product-weapon
tank	product-weapon
destroyer	O
as	O
the	O
d-10s	product-weapon
(	O
for	O
``	O
samokhodnaya	O
''	O
,	O
'self-propelled	O
'	O
)	O
,	O
and	O
was	O
later	O
mounted	O
on	O
the	O
post-war	O
t-54	product-weapon
main	product-weapon
battle	product-weapon
tank	product-weapon
as	O
the	O
d-10t	product-weapon
(	O
for	O
``	O
tankovaya	O
''	O
,	O
'tank	O
'	O
adj	O
.	O
)	O
.	O

pralidoxime	other-medical
is	O
intended	O
to	O
reactivate	O
acetylcholinesterase	O
,	O
but	O
the	O
benefit	O
of	O
oxime	O
treatment	O
is	O
questioned	O
.	O

in	O
1857	O
,	O
a	O
performance	O
followed	O
at	O
notre	building-theater
dame	building-theater
de	building-theater
paris	building-theater
with	O
500	O
participants	O
.	O

morris	product-car
mini	product-car
minor	product-car
and	O
austin	product-car
mini	product-car
)	O
would	O
have	O
the	O
same	O
ado	product-car
number	O
.	O

more	O
recently	O
the	O
l129a1	product-weapon
has	O
come	O
into	O
service	O
as	O
the	O
designated	O
marksman	O
rifle	O
.	O

treatment	O
may	O
include	O
pain	O
medications	O
,	O
nsaids	other-medical
,	O
and	O
elevation	O
.	O

the	O
del	product-car
sol	product-car
was	O
also	O
badged	O
as	O
the	O
cr-x	product-car
del	product-car
sol	product-car
in	O
some	O
markets	O
,	O
and	O
known	O
as	O
simply	O
the	O
cr-x	product-car
in	O
others	O
.	O

it	O
was	O
later	O
designated	O
the	O
``	O
state	building-theater
theater	building-theater
of	building-theater
kentucky	building-theater
``	O
in	O
1974	O
.	O

multiple	O
studies	O
have	O
found	O
docusate	other-medical
to	O
be	O
no	O
more	O
effective	O
than	O
a	O
placebo	O
for	O
improving	O
constipation	O
.	O

there	O
are	O
two	O
further	O
professional	O
productions	O
recorded	O
at	O
the	O
arts	O
archive	O
since	O
the	O
original	O
stephen	building-theater
joseph	building-theater
theatre	building-theater
run	O
,	O
slightly	O
behind	O
``	O
gameplan	O
''	O
and	O
``	O
roleplay	O
''	O
.	O

court	O
acknowledged	O
that	O
physical	O
efficacy	O
of	O
imatinib	other-medical
mesylate	O
in	O
beta	O
crystalline	O
form	O
is	O
enhanced	O
in	O
comparison	O
to	O
other	O
forms	O
and	O
that	O
the	O
beta	O
crystalline	O
form	O
of	O
imatinib	other-medical
mesylate	O
has	O
30	O
per	O
cent	O
increased	O
bioavailability	O
as	O
compared	O
to	O
imatinib	other-medical
in	O
free	O
base	O
form	O
.	O

she	O
believed	O
that	O
he	O
stole	O
it	O
and	O
left	O
her	O
mother	O
to	O
be	O
killed	O
by	O
the	O
hands	O
of	O
kirisakin	other-livingthing
,	O
but	O
was	O
eventually	O
proven	O
wrong	O
when	O
she	O
learned	O
the	O
truth	O
from	O
the	O
sword	O
.	O

the	O
creature	O
likely	O
lived	O
a	O
life	O
similar	O
to	O
that	O
of	O
a	O
modern	O
tapir	other-livingthing
,	O
browsing	O
on	O
foliage	O
and	O
soft	O
vegetation	O
.	O

at	O
one	O
time	O
,	O
it	O
was	O
placed	O
in	O
the	O
old	other-livingthing
world	other-livingthing
babbler	other-livingthing
family	O
,	O
timaliidae	other-livingthing
.	O

the	O
loss	O
and	O
degradation	O
of	O
natural	other-livingthing
temperate	other-livingthing
grassland	other-livingthing
and	O
box-gum	other-livingthing
woodland	other-livingthing
(	O
as	O
described	O
above	O
)	O
throughout	O
the	O
original	O
range	O
of	O
golden	other-livingthing
sun	other-livingthing
moth	other-livingthing
has	O
resulted	O
in	O
a	O
significant	O
reduction	O
of	O
suitable	O
habitat	O
.	O

the	O
sans	building-theater
pareil	building-theater
was	O
significant	O
in	O
the	O
move	O
towards	O
``	O
free	O
''	O
theatre	O
and	O
away	O
from	O
the	O
monopolies	O
that	O
dominated	O
licensed	O
theatre	O
at	O
the	O
time	O
.	O

